HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI Consortium
- PMID: 32372697
- PMCID: PMC7299187
- DOI: 10.2217/pgs-2019-0195
HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI Consortium
Abstract
Aim: To evaluate the association between human leukocyte antigen (HLA) alleles and native Escherichia coli asparaginase hypersensitivity (AH) in children with acute lymphoblastic leukemia (ALL) who received Dana-Farber Cancer Institute treatment protocols. Patients & methods:HLA-DQA1, HLA-DRB1 and HLA-DQB1 alleles were retrieved from available whole exome sequencing data of a subset of childhood ALL patients from Quebec ALL cohort and analyzed for an association with AH. PCR assay was developed to analyze associated alleles in the entire discovery and replication cohorts. Results: Two alleles in linkage disequilibrium (HLA-DRB1*07:01 and DQA1*02:01) were associated with AH. Additional analyses, performed to distinguish between HLA-DRB1*07:01 haplotypes with and without DQB1*02:02 allele, showed that the association was dependent on the presence of DQB1*02:02. Conclusion: This study confirms the implication of HLA-DRB1*07:01, DQA1*02:01 and DQB1*02:02 alleles in developing AH in childhood ALL.
Keywords: SNP; acute lymphoblastic leukemia; asparaginase; asparaginase hypersensitivity; human leukocyte antigen; pharmacogenetics.
Conflict of interest statement
This study was supported by the Canadian Institute for Cancer Research, Leukemia Lymphoma Society of Canada, Cancer Research Society and Charles Bruneau Foundation. Dana-Farber Cancer Institute ALL treatment protocols are supported by the National Cancer Institute/NIH grant 5 P01CA06848. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Similar articles
-
Two tagging single-nucleotide polymorphisms to capture HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype associated with asparaginase hypersensitivity.Br J Clin Pharmacol. 2021 Jun;87(6):2542-2548. doi: 10.1111/bcp.14664. Epub 2020 Dec 16. Br J Clin Pharmacol. 2021. PMID: 33217039 Free PMC article.
-
HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.Haematologica. 2017 Sep;102(9):1578-1586. doi: 10.3324/haematol.2017.168211. Epub 2017 Jun 8. Haematologica. 2017. PMID: 28596278 Free PMC article.
-
HLA-DRB1, -DQA1 and -DQB1 genotyping of 180 Czech individuals from the Czech Republic pop 3.Hum Immunol. 2016 Apr;77(4):365-6. doi: 10.1016/j.humimm.2016.02.003. Epub 2016 Feb 8. Hum Immunol. 2016. PMID: 26867812
-
HLA and Nasal Polyposis Susceptibility: A Meta-analysis of Worldwide Studies.Ann Otol Rhinol Laryngol. 2024 Nov;133(11):940-946. doi: 10.1177/00034894241275476. Epub 2024 Aug 22. Ann Otol Rhinol Laryngol. 2024. PMID: 39175144
-
Family study of monozygotic twins affected by pemphigus vulgaris.Hum Immunol. 2016 Jul;77(7):600-4. doi: 10.1016/j.humimm.2016.05.005. Epub 2016 May 10. Hum Immunol. 2016. PMID: 27177496 Review.
Cited by
-
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity.Clin Pharmacol Ther. 2021 Sep;110(3):794-802. doi: 10.1002/cpt.2241. Epub 2021 Apr 21. Clin Pharmacol Ther. 2021. PMID: 33768542 Free PMC article.
-
Two tagging single-nucleotide polymorphisms to capture HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype associated with asparaginase hypersensitivity.Br J Clin Pharmacol. 2021 Jun;87(6):2542-2548. doi: 10.1111/bcp.14664. Epub 2020 Dec 16. Br J Clin Pharmacol. 2021. PMID: 33217039 Free PMC article.
-
Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences.Pharmaceutics. 2024 Aug 28;16(9):1134. doi: 10.3390/pharmaceutics16091134. Pharmaceutics. 2024. PMID: 39339172 Free PMC article. Review.
-
Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology.Front Pharmacol. 2020 Aug 5;11:1184. doi: 10.3389/fphar.2020.01184. eCollection 2020. Front Pharmacol. 2020. PMID: 32848787 Free PMC article. Review.
-
A Review of L-Asparaginase Hypersensitivity in Paediatric Acute Lymphoblastic Leukaemia Patients with Regard to the Measurement of Anti-Asparaginase Antibodies and Their Genetic Predisposition.Malays J Med Sci. 2023 Oct;30(5):40-51. doi: 10.21315/mjms2023.30.5.4. Epub 2023 Oct 30. Malays J Med Sci. 2023. PMID: 37928798 Free PMC article. Review.
References
-
- Abaji R, Krajinovic M. Current perspective on pediatric pharmacogenomics. Expert Opin. Drug Metab. Toxicol. 12(4), 363–365 (2016). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous